Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A exposure before conception or during pregnancy registry
ChiCTR2000033484Phase 4Recruiting
- Sponsor
- Women's Hospital, School of Medicine, Zhejiang University
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A in pregnancy (2 arms), sponsored by Women's Hospital, School of Medicine, Zhejiang University. Primary endpoint: Congenital defect. Started Jan 2016; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
pregnancy
Beyond the preview
Go deeper on ChiCTR2000033484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033484.